Paris - Delayed Quote EUR

Innate Pharma S.A. (IPH.PA)

1.9480
+0.0120
+(0.62%)
As of 9:41:02 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
12,621
12,621
51,901
49,580
12,110
Operating Expense
64,197
64,197
64,570
66,005
59,937
Operating Income
-51,576
-51,576
-12,669
-16,425
-47,827
Net Non Operating Interest Income Expense
1,871
1,871
2,537
258
15
Other Income Expense
232
232
2,562
-41,805
2,330
Pretax Income
-49,471
-49,471
-7,570
-57,972
-45,478
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-49,471
-49,471
-7,570
-58,103
-52,809
Diluted NI Available to Com Stockholders
-49,471
-49,471
-7,570
-58,103
-52,809
Basic EPS
-0.61
-0.61
-0.09
-0.73
-0.66
Diluted EPS
-0.61
-0.61
-0.09
-0.73
-0.66
Basic Average Shares
81,051.7980
81,051.7980
80,453.2820
79,639.8260
79,542.6270
Diluted Average Shares
81,051.7980
81,051.7980
80,453.2820
79,639.8260
79,542.6270
Total Operating Income as Reported
-51,575
-51,575
-12,669
-57,425
-47,825
Total Expenses
64,197
64,197
64,570
66,005
59,937
Net Income from Continuing & Discontinued Operation
-49,471
-49,471
-7,570
-58,103
-52,809
Normalized Income
-49,703
-49,703
-10,132
-16,167
-47,808
Interest Income
2,437
2,437
3,177
546
327
Interest Expense
566
566
640
288
312
Net Interest Income
1,871
1,871
2,537
258
15
EBIT
-48,905
-48,905
-6,930
-57,684
-45,166
EBITDA
-46,911
-46,911
-1,839
-12,279
-40,570
Reconciled Depreciation
1,994
1,994
5,091
45,405
4,596
Net Income from Continuing Operation Net Minority Interest
-49,471
-49,471
-7,570
-57,972
-45,478
Total Unusual Items Excluding Goodwill
232
232
2,562
-41,805
2,330
Total Unusual Items
232
232
2,562
-41,805
2,330
Normalized EBITDA
-47,143
-47,143
-4,401
29,526
-42,900
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/1/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ADOC.PA Adocia SA
3.4550
-1.85%
 
ALOPM.PA Oncodesign Precision Medicine Société anonyme
0.3200
+2.89%
 
GLPG.VI Galapagos NV
25.80
+1.42%
 
ALCOX.PA Nicox S.A.
0.2260
0.00%
 
ALGEN.PA genOway Société anonyme
3.1400
0.00%
 
AZT.OL ArcticZymes Technologies ASA
16.30
0.00%
 
GNFT.PA Genfit S.A.
3.9580
0.00%
 
ALGAE.PA FERMENTALG
0.5500
-1.79%
 
ABNX.PA ABIONYX Pharma SA
1.3060
0.00%
 
ALNEV.PA Neovacs S.A.
0.0032
+6.67%